although showing no statistical differences between the 3 treatment regimens , the results support the view that a combination of mp 'standard ' induction therapy in mm with frequently administered vincristine has a trend towards postponing treatment failure due to development of resistance to melphalan .
C0284383
mp
C0025241
melphalan